Steve R. Turner - Concepedia

Author

Steve R. Turner

W.E. Upjohn Institute for Employment Research

Also Known As

Steve R. Turner

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research

About

Steve R. Turner is an author at W.E. Upjohn Institute for Employment Research specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	777
2	Biochemistry	12	12	777
3	Natural Sciences	10	10	685
4	Allergy	1	1	25
5	Allergy Medicine	1	1	25

Steve R. Turner

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class Steve R. Turner, Joseph W. Strohbach, Rubén Tommasi, Journal of Medicinal Chemistry	1998	293
Design and synthesis of potent and specific renin inhibitors containing difluorostatine, difluorostatone, and related analogs Suvit Thaisrivongs, Donald T. Pals, Warren M. Kati, Journal of Medicinal Chemistry Tetrahedral IntermediateBioorganic ChemistryPharmacotherapyChemical BiologyPharmaceutical Chemistry	1986	134
Structure-Based Design of Novel HIV Protease Inhibitors: Carboxamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Nonpeptidic Inhibitors Suvit Thaisrivongs, Keith David Watenpaugh, W. Jeffrey Howe, Journal of Medicinal Chemistry	1995	121
Structure-Based Design of HIV Protease Inhibitors: Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors Suvit Thaisrivongs, Harvey I. Skulnick, Steve R. Turner, Journal of Medicinal Chemistry Hiv Protease InhibitorsPharmacotherapyAntiviral DrugChemical BiologyDrug Metabolism Research	1996	96
Structure-Based Design of Novel HIV Protease Inhibitors: Sulfonamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Non-Peptidic Inhibitors Suvit Thaisrivongs, Musiri N. Janakiraman, Kong-Teck Chong, Journal of Medicinal Chemistry Hiv Protease InhibitorsPeptide ScienceAntiviral DrugPharmaceutical ChemistryMolecular Pharmacology	1996	88
Structure-Based Design of HIV Protease Inhibitors: 5,6-Dihydro-4-hydroxy-2-pyrones as Effective, Nonpeptidic Inhibitors Suvit Thaisrivongs, Donna L. Romero, Rubén Tommasi, Journal of Medicinal Chemistry Crystal StructureBioorganic ChemistryAntiviral DrugChemical BiologyMedicinal Chemistry	1996	86
Renin inhibitors. Design of angiotensinogen transition-state analogs containing novel (2R,3R,4R,5S)-5-amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic acid Suvit Thaisrivongs, Donald T. Pals, Lisa T. Kroll, Journal of Medicinal Chemistry Renin Inhibitory PeptidesRenin Inhibitors-5-Amino-3,4-dihydroxy-2-isopropyl-7-methyloctanoic AcidCardiovascular PharmacologyPharmacotherapy	1987	71
Difluorostatine and difluorostatone containing peptides as potent and specific renin inhibitors Suvit Thaisrivongs, Donald T. Pals, Warren M. Kati, Journal of Medicinal Chemistry Preclinical TherapeuticsPharmaceutical ScienceAltmetric Attention ScorePeptide SciencePharmacotherapy	1985	65
Conformationally constrained renin inhibitory peptides: .gamma.-lactam-bridged dipeptide isostere as conformational restriction Suvit Thaisrivongs, Donald T. Pals, Steve R. Turner, Journal of Medicinal Chemistry Renin Inhibitory PeptidesProtein AssemblyMolecular BiologyHuman Plasma ReninMolecular Pharmacology	1988	62
Design and synthesis of a potent and specific renin inhibitor with a prolonged duration of action in vivo Suvit Thaisrivongs, Donald T. Pals, Douglas W. Harris, Journal of Medicinal Chemistry Backbone C Alpha-methylPeptide SciencePharmacotherapyHuman Plasma ReninPharmaceutical Chemistry	1986	52

Page 1